K. Lewis et al., EFFECT OF NEUROPEPTIDE-Y ON BRADYKININ-INDUCED RELEASE OF PROSTACYCLIN AND THROMBOXANE FROM GUINEA-PIG PERFUSED LUNG, Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 677-682
We have previously reported that neuropeptide Y (NPY) inhibits respons
es induced by various agonists (noradrenaline, vasoactive intestinal p
eptide, substance P,5-hydroxytryptamine) in isolated guinea pig trache
a. Although the underlying mechanisms have not been fully characterize
d, it was found that the NPY-evoked inhibition was specifically expres
sed with agents for which locally released prostaglandins (PGs) are im
portant determinants for their myotropic activity. In the present stud
y, we have extended these findings by examining whether NPY was capabl
e of regulating the release of prostacyclin and thromboxane A,induced
by bradykinin (BK) from naive and ovalbumin-sensitized guinea pig perf
used lungs. Our results showed that infusion of NPY (0.24 mu M) throug
h the lung significantly inhibited the release of 6-keto-PGF(1 alpha)
(>30%) and thromboxane B-2 (50%) induced by intraarterial administrati
on of BK (3 mu g) from untreated and ovalbumin-sensitized guinea pig p
erfused lung. However, the inhibitory effect of NPY was lost in the im
munological production of prostaglandins. These results suggest that N
PY may act as a regulatory agent of the release of cyclooxygenase-deri
ved products by possibly acting on events preceding phospholipase A(2)
activation.